GRAIL, LLC NASDAQ:GRAL

GRAIL stock price today

$31.89
+12.29
+62.7%
Financial Health
0
1
2
3
4
5
6
7
8
9

GRAIL stock price monthly change

+32.34%
month

GRAIL stock price quarterly change

+32.34%
quarter

GRAIL key metrics

Market Cap
626.15M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
N/A
Revenue
N/A
EBITDA
N/A
Income
N/A
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

GRAIL stock price history

GRAIL stock forecast

GRAIL financial statements

GRAIL, LLC (NASDAQ:GRAL): Profit margin
2020 0 -312.15M
2023 93.10M -1.46B -1574.23%
GRAIL, LLC (NASDAQ:GRAL): Debt to assets
2023 3913814000 267.62M 6.84%
GRAIL, LLC (NASDAQ:GRAL): Cash Flow
2023 -595.8M -12.88M 463.76M

GRAIL alternative data

GRAIL, LLC (NASDAQ:GRAL): Employee count
Dec 2024 1,360

GRAIL other data

Wednesday, 18 December 2024
prnewswire.com
Saturday, 14 December 2024
marketbeat.com
Thursday, 5 December 2024
marketwatch.com
Tuesday, 3 December 2024
prnewswire.com
Tuesday, 19 November 2024
prnewswire.com
Monday, 18 November 2024
prnewswire.com
Friday, 15 November 2024
seekingalpha.com
Tuesday, 12 November 2024
prnewswire.com
Monday, 4 November 2024
prnewswire.com
Tuesday, 29 October 2024
prnewswire.com
Sunday, 27 October 2024
seekingalpha.com
Wednesday, 23 October 2024
prnewswire.com
Monday, 21 October 2024
prnewswire.com
Sunday, 13 October 2024
247wallst.com
Friday, 4 October 2024
seekingalpha.com
Thursday, 3 October 2024
globenewswire.com
Tuesday, 24 September 2024
seekingalpha.com
Monday, 9 September 2024
seekingalpha.com
Tuesday, 3 September 2024
reuters.com
Friday, 30 August 2024
prnewswire.com
247wallst.com
Thursday, 29 August 2024
prnewswire.com
Wednesday, 21 August 2024
prnewswire.com
Tuesday, 20 August 2024
seekingalpha.com
Tuesday, 13 August 2024
seekingalpha.com
reuters.com
prnewswire.com
Wednesday, 31 July 2024
prnewswire.com
Thursday, 18 July 2024
prnewswire.com
Wednesday, 17 July 2024
investorplace.com
  • What's the price of GRAIL stock today?

    One share of GRAIL stock can currently be purchased for approximately $31.89.

  • When is GRAIL's next earnings date?

    Unfortunately, GRAIL's (GRAL) next earnings date is currently unknown.

  • Does GRAIL pay dividends?

    No, GRAIL does not pay dividends.

  • How much money does GRAIL make?

    GRAIL has a market capitalization of 626.15M.

  • What is GRAIL's stock symbol?

    GRAIL, LLC is traded on the NASDAQ under the ticker symbol "GRAL".

  • What is GRAIL's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of GRAIL?

    Shares of GRAIL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does GRAIL have?

    As Dec 2024, GRAIL employs 1,360 workers.

  • When GRAIL went public?

    GRAIL, LLC is publicly traded company for just a year since IPO on 12 Jun 2024.

  • What is GRAIL's official website?

    The official website for GRAIL is grail.com.

  • Where are GRAIL's headquarters?

    GRAIL is headquartered at 1525 O’Brien Drive, Menlo Park, CA.

  • How can i contact GRAIL?

    GRAIL's mailing address is 1525 O’Brien Drive, Menlo Park, CA and company can be reached via phone at 833-694-2553.

GRAIL company profile:

GRAIL, LLC

grail.com
Exchange:

NASDAQ

Full time employees:

1,360

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

1525 O’Brien Drive
Menlo Park, CA 94025

CIK: 0001699031
ISIN: US3847471014
: